Bone Marrow Transplant: Who Needs It, How It Works and What to Expect

What Is a Bone Marrow Transplant?

A bone marrow transplant is a treatment that replaces damaged or unhealthy blood-forming stem cells with healthy ones.

These stem cells create red blood cells, white blood cells and platelets. Although the term “bone marrow transplant” is commonly used, stem cells can also be collected from the bloodstream or umbilical cord blood.

The broader medical term is hematopoietic stem cell transplantation.

Who May Need a Bone Marrow Transplant?

Stem cell transplantation may be considered for several cancers and blood disorders, including:

• Leukemia
• Lymphoma
• Multiple myeloma
• Myelodysplastic syndromes
• Aplastic anemia
• Certain inherited blood disorders
• Some immune system disorders

Whether transplantation is appropriate depends on the specific disease, its stage, previous treatments, the patient's age and general health, and whether a suitable donor is available when donor cells are required.

What Are the Main Types of Transplant?

There are two main approaches.

Autologous Transplant

In an autologous transplant, the patient's own healthy stem cells are collected before intensive treatment and stored.

The patient then receives high-dose chemotherapy, sometimes combined with radiation therapy, after which the stored stem cells are returned to the body.

This approach is used in certain diseases such as multiple myeloma and some lymphomas.

Allogeneic Transplant

In an allogeneic transplant, stem cells come from another person.

The donor may be a family member or an unrelated donor whose tissue type is sufficiently compatible with the patient.

Donor transplantation can replace diseased blood-forming cells with healthy donor cells. In some blood cancers, the donor's immune cells may also attack remaining cancer cells.

How Is a Donor Matched?

For an allogeneic transplant, doctors compare markers called human leukocyte antigens, or HLA.

HLA matching is more detailed than simply having the same blood group.

A close match improves the chance that donor cells will successfully establish themselves in the patient's bone marrow and can reduce the risk of complications.

If a fully matched donor is unavailable, the transplant team may consider other options depending on the patient's condition and available donors.

What Happens Before the Transplant?

Patients undergo a comprehensive evaluation before transplantation.

This may include:

• Blood tests
• Heart and lung assessment
• Kidney and liver function tests
• Infection screening
• Imaging examinations
• Evaluation of the underlying disease

Before receiving the stem cells, the patient usually undergoes conditioning treatment with chemotherapy and sometimes radiation therapy.

Conditioning helps destroy diseased cells, suppress the immune system when necessary and prepare the bone marrow for the new stem cells.

How Are the Stem Cells Given?

The actual stem cell infusion is usually given through a vein, similar to a blood transfusion.

Once inside the bloodstream, the stem cells travel to the bone marrow. There they begin producing new blood cells.

This process is called engraftment.

Doctors regularly monitor blood counts after transplantation to determine when the new stem cells have started working.

Recovery After Bone Marrow Transplant

During the early recovery period, the patient's immune system is weak and blood cell levels may be very low.

Patients are therefore monitored closely for infection, bleeding and other complications.

Hospitalization can last several weeks depending on the type of transplant and the patient's condition.

After discharge, frequent blood tests and follow-up visits are required. Full recovery of the immune system can take months, and in some donor transplants it may take considerably longer.

What Is Graft-Versus-Host Disease?

Graft-versus-host disease, or GVHD, is a possible complication of allogeneic transplantation.

It occurs when immune cells from the donor recognize the patient's tissues as foreign and attack them.

GVHD can affect areas such as the skin, digestive system, liver, mouth, eyes or lungs.

Doctors use medications to reduce the risk and severity of GVHD, and patients receiving donor cells are monitored carefully for symptoms.

What Are the Main Risks?

Bone marrow and stem cell transplantation can cause significant complications, including:

• Serious infections
• Bleeding or anemia while blood counts recover
• Graft-versus-host disease after donor transplantation
• Organ complications
• Side effects from chemotherapy or radiation
• Failure of the transplanted cells to establish themselves
• Return of the original disease

The risks vary greatly depending on the disease, transplant type, donor compatibility and patient's overall health.

Life After Transplantation

Recovery does not end when the patient leaves the hospital.

Regular follow-up is essential to monitor blood counts, immune recovery, infection risk and the original disease.

Patients may need preventive medicines, vaccinations, dietary precautions and temporary restrictions on travel or exposure to infections.

Bone marrow transplantation is a complex treatment rather than a single procedure. Patients who may need transplantation should be evaluated by an experienced hematology and transplant team to determine whether transplantation is appropriate and which type offers the best option for their individual condition.